The price reduction is being enabled by cutting the list price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25 a vial. List prices for drugs often differ from what ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic ...

Ellison accused Novo Nordisk, Eli Lilly and Sanofi of inflating patients' out-of-pocket costs for insulin based on the wholesale acquisition cost, or list price, of the drug. The drugmakers were ...

He added his office’s goal is to make sure insulin prices do not increase after these five years. During the press conference, Ellison said diabetic patients were paying about $6,000 a year on ...

An executive order signed by former President Joe Biden aimed at lowering prescription drug prices was among those voided by President Donald Trump's flurry of executive orders this week.

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Like Eli Lilly and Sanofi, Novo Nordisk has agreed to implement a texting system to assist pharmacists and patients to determine eligibility for low-cost insulin, and alert patients about this low ...